Bioneer A/S is an innovative research-based CRO company, providing services within biomedicine and biotechnology.

Our commercial mission is to increase the competitiveness of our global customers by facilitating their early, explorative development of new therapeutics. We therefore offer access to essential tools, technology and unique biological resources within cell and molecular biology, and we further aim to create new product opportunities at the interface between biology and other sciences.

Bioneer A/S has 4 major areas of interest:

• Protein production: Recombinant protein production using endotoxin free Lactococcal system P170 or E. coli royalty free constructions
• Immune targeting: Investigating immune-regulatory properties of drug candidates in early drug discovery. Anti-inflammatory screening systems based on dendritic and T-cell proliferation
• Compound characterization and formulation: Covering the field from lead identification to final formulation of the active compound
• Biomarkers: Identification, validation and visualisation of biomarkers. Profiling of miRNA for development of diagnostic systems. Phage-display technology for identification of rare cell protein epitopes. Simultaneously multi immunohistochemical assays for in situ inspection of tissue.

Bioneer A/S is a high value-partner for:

• Research contract
• Production contract
• Drug Product Development and Full Pharmaceutical Service contract
• Partnering
• Consultancy & Services
• Feasibility contract